ARCHIVES

HER2+ Tumors Increase Risk Of Recurrence, Study Finds

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | November 27, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Plans Greater Disclosures Over Wide Range Of Activities

May 21, 2010

Breast Cancers Detected By Mammograms Have Better Prognosis, Trials Analysis Finds

September 30, 2005

Also: Court Will Reconsider Ruling on Access To Experimental Drugs.

December 1, 2006

Nader Group Backs FDA In controversy Over Drug Testing

February 11, 1977

NCI Chips In $2 Million For AACR Meeting; Advisors, Senior Staff Not Consulted.

June 20, 2003

Senate committee approves $1.1 billion increase for NIH.

October 1, 2004